Statistics

Total Visits

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.94

Select a period of time:

Number of views in the range

Views
First line with bevacizumab in combination with paclitaxel (P) and gemcitabine (G) in patients with HER2-negative or recurrent mBC: First PFS analysis.17

Views

Views
November 20251
December 20253
January 20260
February 20260
March 20264
April 20265
May 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
United Kingdom2
China2
Argentina1
Brazil1
Chile1
Colombia1
Kenya1
Nicaragua1
 

Top cities views

Views
Los Angeles3
Ashburn1
Coatesville1
Concepción1
Fort Wayne1
Livingston1
Managua1
Medellín1
Miami1
Moreno1